Litcius/Paper detail

Procoagulant Phosphatidylserine-Exposing Platelets in vitro and in vivo

Emily C. Reddy, Margaret L. Rand

2020Frontiers in Cardiovascular Medicine165 citationsDOIOpen Access PDF

Abstract

The physiological heterogeneity of platelets leads to diverse responses and the formation of discrete subpopulations upon platelet stimulation. Procoagulant platelets are an example of such subpopulations, a key characteristic of which is exposure either of the anionic aminophospholipid phosphatidylserine (PS) or of tissue factor on the activated platelet surface. This review focuses on the former, in which PS exposure on a subpopulation of platelets facilitates assembly of the intrinsic tenase and prothrombinase complexes, thereby accelerating thrombin generation on the activated platelet surface, contributing importantly to the hemostatic process. Mechanisms involved in platelet PS exposure, and accompanying events, induced by physiologically relevant agonists are considered then contrasted with PS exposure resulting from intrinsic pathway-mediated apoptosis in platelets. Pathologies of PS exposure, both inherited and acquired, are described. A consideration of platelet PS exposure as an antithrombotic target concludes the review.

Topics & Concepts

PlateletProthrombinasePhosphatidylserineCell biologyPlatelet activationThrombinChemistryCoagulationIn vitroTissue factorIn vivoStimulationImmunologyBiologyMedicineBiochemistryInternal medicineNeurosciencePhospholipidMembraneBiotechnologyPlatelet Disorders and TreatmentsPhagocytosis and Immune RegulationBlood Coagulation and Thrombosis Mechanisms